(Q73218719)
Statements
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered (English)
J C Byrd
R K Dodge
A Carroll
M R Baer
C Edwards
J Stamberg
J O Moore
R J Mayer
F Davey
C A Schiffer
1 December 1999